Regulatory News: IBS' (STO:IBSB) new share issue with preferential rights for the
Company's existing shareholders has been completed. The final outcome
of the rights issue will be announced on Thursday, July 10. The
preliminary outcome is as follows.
Deccan Value Advisors, having issued a subscription guarantee,
subscribed for its pro rata share of the rights issue and an
additional 75,000 class A shares and an additional 11,087,943 class B
shares. Accordingly, the rights issue was subscribed for in its
entirety. Following completion of the rights issue, Deccan Value
Advisors owns 17.1 percent of the shares and 36.9 percent of the votes
in IBS.
As a consequence of the rights issue, the number of shares in IBS
increases by 1,575,000 class A shares and 40,229,015 class B shares. Following the issue, 4,725,000 class A shares and 120,687,045 class B
shares will be outstanding.
Trading in the new class B shares on OMX Nordic Exchange Stockholm
is scheduled to commence on July 17, 2008.
The rights issue will provide the company with approximately SEK
397 million before transaction costs.
Additional class B shares will be issued shortly as consideration
for Deccan Value Advisors subscription guarantee. The exact number of
shares issued will be stated in a separate press release as soon as
the formal resolution to issue the shares has been adopted.
IBS AB Board of Directors IBS (OMX Nordic Exchange STO: IBS) is a leading provider of
specialized business systems for specific industries such as
publishing and book distribution, pharmaceutical distribution,
electrical and electronic parts and equipment, paper, food and the
automotive industry. IBS focuses on large and mid-sized companies
within supply chain management, demand-driven manufacturing, customer
administration and financial control. For further information, visit
www.ibs.net This information was brought to you by Cision
http://newsroom.cision.com
Regulatory News:
IBS’ (STO:IBSB) new share issue with
preferential rights for the Company’s existing
shareholders has been completed. The final outcome of the rights issue
will be announced on Thursday, July 10. The preliminary outcome is as
follows.
Deccan Value Advisors, having issued a subscription guarantee,
subscribed for its pro rata share of the rights issue and an additional
75,000 class A shares and an additional 11,087,943 class B shares.
Accordingly, the rights issue was subscribed for in its entirety.
Following completion of the rights issue, Deccan Value Advisors owns
17.1 percent of the shares and 36.9 percent of the votes in IBS.
As a consequence of the rights issue, the number of shares in IBS
increases by 1,575,000 class A shares and 40,229,015 class B shares.
Following the issue, 4,725,000 class A shares and 120,687,045 class B
shares will be outstanding.
Trading in the new class B shares on OMX Nordic Exchange Stockholm is
scheduled to commence on July 17, 2008.
The rights issue will provide the company with approximately SEK 397
million before transaction costs.
Additional class B shares will be issued shortly as consideration for
Deccan Value Advisors subscription guarantee. The exact number of shares
issued will be stated in a separate press release as soon as the formal
resolution to issue the shares has been adopted.
IBS AB
Board of Directors
IBS (OMX Nordic Exchange STO: IBS) is a leading provider of
specialized business systems for specific industries such as publishing
and book distribution, pharmaceutical distribution, electrical and
electronic parts and equipment, paper, food and the automotive industry.
IBS focuses on large and mid-sized companies within supply chain
management, demand-driven manufacturing, customer administration and
financial control. For further information, visit www.ibs.net
This information was brought to you by Cision http://newsroom.cision.com
|